Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation

QR Code

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation

Introduction. Based on clinical studies data voriconazole is recommended as the drug of choice for treatment of invasive aspergillosis (IA) – a widespread infectious complications occurring in immunocompromised patients and is characterized by severe clinical course and high mortality.The aim of thi...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. I. Ignatieva, M. V. Avksentieva
Format:	Article
Language:	Russian
Published:	ABV-press 2015-06-01
Series:	Онкогематология
Subjects:	invasive aspergillosis pharmacoeconomics modeling cost-effectiveness voriconazole caspofungin amphotericin b amphotericin b lipid complex cost-benefit analysis efficiency analysis sensitivity analysis
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/141
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative efficacy of intrastromal amphotericin B versus voriconazole in treating deep-stromal refractory fungal keratitis
by: Charul Singh, et al.
Published: (2025-07-01)

Fusarium isolates in burn-injured patients: Clinical characteristics and susceptibility patterns
by: Robyn Stoianovici, et al.
Published: (2025-07-01)

Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

Modulating the Antifungal Activity of Antimycotic Drugs with Farnesol
by: N. P. Sachivkina, et al.
Published: (2021-11-01)

Invasive aspergillosis in patients with acute myeloid leukemia: difficulties in choosing first-line therapy in real clinical practice and pharmacoeconomic analysis of the feasibility of using new antifungal drugs
by: Yu. S. Osipov, et al.
Published: (2025-05-01)

Comparing the results of invasive candidiasis prevention with anidulafungin vs. the lipid formulation of amphotericin B in high-risk patients in the early postoperative period after liver transplantation
by: S. V. Zhuravel, et al.
Published: (2020-06-01)

Rhinocerebral Form of Invasive Mycosis in COVID-19 Patients: Clinical Course, Diagnosis, Treatment Experience
by: Yu. V. Savosin, et al.
Published: (2022-10-01)

Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case report
by: Soo Kyun Jung, et al.
Published: (2025-01-01)

Fungal Keratitis. Part 2. Diagnosis and Treatment
by: O. V. Shilovskikh, et al.
Published: (2023-12-01)

Fungal Endophthalmitis. Literature Review
by: V. N. Kazaykin, et al.
Published: (2020-11-01)

Clinic-morphological characteristics of Cryptococcosis in HIV-infective patients
by: I. P. Charushina, et al.
Published: (2014-09-01)

Pharmacoeconomic analysis of the anidulafungin (EraxisR) in adult patients with invasive candidiasis
by: S. V. Nedogoda, et al.
Published: (2019-10-01)

Analysis of Spectral Characteristics of Certain Polyene Antibiotics in the Presence of Dmso and Cholesterol
by: G. H. Sultanova, et al.
Published: (2024-03-01)

Invasive pulmonary aspergillosisas a complication of severe influenza (case report)
by: Yu. E. Melekhina, et al.
Published: (2020-03-01)

Successful treatment of pulmonary mucormycosis in a child with aplastic anemia
by: Ye. A. Nikitina, et al.
Published: (2014-07-01)

Inhibiting Effect of Macrolide Polyene Antibiotics on Reproduction of Viruses
by: A. A. Bagirova, et al.
Published: (2020-05-01)

Cutaneous leishmaniasis in a renal transplant patient: Diagnostic challenges in a non-endemic setting
by: Zishan Nasir, et al.
Published: (2025-01-01)

Efficacy and Safety of Amphotericin B Colloidal Dispersion via Nebulized Inhalation Combined with Intravenous Therapy for Invasive Pulmonary Fungal Disease: A Single-Center, Retrospective Cohort Study
by: Li Z, et al.
Published: (2025-07-01)

Reworking the treatment of Indian Post kala-azar dermal leishmaniasis: A two-step therapy
by: Sushruta Kathuria, et al.
Published: (2025-04-01)

Antifungal Activity of Selected Naphthoquinones and Their Synergistic Combination with Amphotericin B Against <i>Cryptococcus neoformans</i> H99
by: Naira Sulany Oliveira de Sousa, et al.
Published: (2025-06-01)

Mucormycosis in children with hematological and oncological diseases in saint-petersburg
by: N. N. Klimko, et al.
Published: (2016-11-01)

Case Report: Omalizumab combined with voriconazole for the treatment of ABPA complicating IPA: a case report
by: Tingrui Zhao, et al.
Published: (2025-07-01)

Endovascular Infusion of Amphotericin B for the Treatment of Rhino-Orbito-Cerebral Mucormycosis: A Pilot Study Assessing Technical Feasibility and Safety
by: Subhash Kumar, et al.
Published: (2022-07-01)

Synergistic Combination of Amphotericin B and Antiseptic Miramistin May Be Effective in the Fight Against Drug-Resistant Isolates of Candida Fungi
by: M. A. Кirsanova, et al.
Published: (2022-12-01)

Cost-effectiveness of Voriconasole in treatment of invasive aspregillosis
by: N. N. Climko, et al.
Published: (2014-09-01)

Novel treatment possibilities of invasive aspergillosis
by: G. A. Klyasova
Published: (2021-11-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2016-06-01)

Clove Oil-Based Nanoemulsion Containing Amphotericin B as a Therapeutic Approach to Combat Fungal Infections
by: Marcel Lucas de Almeida, et al.
Published: (2025-07-01)

Three case reports of pulmonary mucormycosis with a review of the literature
by: Zhengyang Zhang, et al.
Published: (2025-07-01)

COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Current Challenges in the Treatment of Invasive Aspergillosis in Geriatric Patients
by: Sara Fueyo Álvarez, et al.
Published: (2025-06-01)

Comprehensive analysis of Amphotericin B: innovations and clinical applications in tropical dermatoses and beyond – A narrative review
by: Aditya K. Bubna, et al.
Published: (2025-04-01)

ECONOMIC ASSESSMENT OF MAGNESIUM DEFICIENCY CORRECTION FOR BASIC THERAPY EFFICACY OF UNCONTROLLED ASTHMA IN CHILDREN
by: V. I. Petrov, et al.
Published: (2015-03-01)

Invasive pulmonary aspergillosis after heart transplantation
by: M. A. Simonenko, et al.
Published: (2021-07-01)

Invasive aspergillosis in adult patients with rheumatic diseases
by: V. I. Mazurov, et al.
Published: (2020-11-01)

Invasive pulmonary aspergillosis in COVID-19 patients
by: V. G. Gusarov, et al.
Published: (2021-03-01)

A Rare Case of Disseminated Histoplasmosis in a Postrenal Transplant Patient
by: Vishal Parmar, et al.
Published: (2025-04-01)

INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-07-01)

Who benefits from fleet electrification? quantifying the costs and benefits of transportation electrification strategies from different perspectives
by: J.Andrew Kelly, et al.
Published: (2025-07-01)